| Literature DB >> 23527162 |
Chihiro Sutoh1, Michiko Nakazato, Daisuke Matsuzawa, Kadushi Tsuru, Tomihisa Niitsu, Masaomi Iyo, Eiji Shimizu.
Abstract
OBJECTIVE: The aim of this study is to clarify the symptomatology of the eating disorders examining the prefrontal function and activity associated with self-regulation among participants with or without eating disorders.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23527162 PMCID: PMC3602060 DOI: 10.1371/journal.pone.0059324
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Demographics of all participants, and scores of symptom scales relevant to the ED group.
| HC (N = 14) | ED (total N = 24) | η2 | |||||||||||||
| Total | AN (N = 10) | BN (N = 14) | |||||||||||||
| mean | SD | mean | SD | N | mean | SD | N | mean | SD | N | |||||
| Age | 24.1 | 3.0 | 26.1 | 7.1 | 24 | 27.7 | 8.4 | 10 | 25.0 | 6.1 | 14 | 0.06 | |||
| Height | 159.7 | 4.9 | 157.4 | 4.6 | 23 | 157.1 | 4.7 | 10 | 157.7 | 4.7 | 13 | 0.06 | |||
| Weight | 53.7 | 7.5 | 45.8 | 8.2 | 23 | 42.2 | 8.7 | 10 | 48.6 | 6.9 | 13 | 0.28 | |||
| BMI | 21.0 | 2.2 | 18.5 | 3.2 | 23 | 17.0 | 3.1 | 10 | 19.6 | 3.0 | 13 | 0.27 | |||
| Period of illness (months) | 67.6 | 53.5 | 21 | 42.7 | 34.6 | 7 | 80.1 | 57.9 | 14 | ||||||
| Treatment period (months) | 36.6 | 42.9 | 20 | 19.4 | 16.8 | 7 | 45.9 | 50.1 | 13 | ||||||
| Antidepressants treatment | 4 | 0 | 4 | ||||||||||||
| Antipsychotics treatment | 3 | 2 | 1 | ||||||||||||
| Anxiolytics treatment | 8 | 2 | 6 | ||||||||||||
| History of hospitalization | (11 of 20 patients had) | (5 of 7 patients had) | (6 of 13 patients had) | ||||||||||||
| HADS | Anxiety | 3.3 | 1.9 | 11.1 | 3.0 | 24 | 10.8 | 3.0 | 10*** | 11.4 | 3.1 | 14*** | 0.69 | ||
| Depression | 1.8 | 1.6 | 9.3 | 3.7 | 24 | 6.8 | 3.4 | 10*** | 11.1 | 2.8 | 14*** | 0.72 | |||
| EDI | 127.9 | 41.4 | 15 | 107.3 | 42.4 | 6 | 141.6 | 36.8 | 9 | ||||||
| EDE-Q | Global | 3.9 | 1.3 | 16 | 3.3 | 1.5 | 6 | 4.2 | 1.1 | 10 | |||||
| Restraint | 3.3 | 1.7 | 16 | 3.4 | 1.8 | 6 | 3.2 | 1.6 | 10 | ||||||
| Eating | 3.9 | 1.5 | 17 | 3.4 | 1.8 | 7 | 4.2 | 1.4 | 10 | ||||||
| Weight | 4.2 | 1.6 | 17 | 3.4 | 1.7 | 7 | 4.7 | 1.3 | 10 | ||||||
| Shape | 4.4 | 1.3 | 16 | 3.8 | 1.6 | 6 | 4.7 | 1.1 | 10 | ||||||
| BITE | Severity | 13.4 | 5.8 | 13 | 12.0 | 7.1 | 4 | 14.0 | 5.5 | 9 | |||||
| Symptom | 22.9 | 3.5 | 13 | 22.0 | 5.3 | 4 | 23.3 | 2.6 | 9 | ||||||
| TAS-20 | 65.4 | 5.2 | 15 | 63.4 | 3.5 | 5 | 66.4 | 5.7 | 10 | ||||||
Notes: One-way analysis of variances was performed to compare age, height, weight, BMI and HADS subscales between the HC, AN and BN groups. HC, healthy control; ED, eating disorder; AN, anorexia nervosa; BN bulimia nervosa; SD, standard deviation; BMI, body mass index; HADS, Hospital Anxiety and Depression Scale; EDI, the Eating Disorder Inventory; EDE-Q, the Eating Disorder Examination Questionnaire, BITE, the Bulimic Investigatory Test; TAS-20, the 20-item Toronto Alexithymia Scale. Significant differences between each patient group with the HC group were shown with ***p<0.001,
p<0.01 or *p<0.05.
Figure 1Task procedures of the word fluency task (WFT) and the rock-paper-scissors intentional loss task (RPSTloss).
(A) Time schedule of one trial of the WFT. (B) Visual instructions presented in the WFT. A set of three different syllables was presented for 20 sec each during a 60-sec task period, to serve as the initial syllables for word generation. During the pretask and posttask periods, participants were instructed to repeat the presented five syllables in turn. (C) Time schedule and instructions of one trial of the RPSTloss. (D) Three hand shape pictures presented in the RPSTloss. The same pictures were used during the pretask, task, and posttask periods.
Figure 2Brain sites observed with near infrared spectroscopy.
The oxyhemoglobin concentrations in the left and right regions (channels 1 and 2, respectively) over the lower dorsolateral prefrontal to orbitofrontal areas were measured. These regions are labelled in the standard brain space [38], [39].
Correlation coefficients of prefrontal activity with task performances and symptom scales.
| AN | BN | ||||||||
| left | right | Left | Right | ||||||
|
|
|
|
|
|
|
|
| ||
| HADS | Anxiety | 0.400 | 0.253 | 0.177 | 0.625 | −0.267 | 0.357 | −0.187 | 0.522 |
| Depression | 0.465 | 0.176 | 0.461 | 0.180 | −0.049 | 0.868 | 0.080 | 0.786 | |
| EDI | −0.040 | 0.940 | −0.188 | 0.721 | 0.054 | 0.890 | 0.619 | 0.075 | |
| EDE-Q | Global | −0.377 | 0.462 | −0.415 | 0.413 | 0.210 | 0.561 | 0.690 | 0.027* |
| Restraint | −0.190 | 0.718 | −0.442 | 0.380 | 0.675 | 0.032* | 0.896 | 0.000* | |
| Eating concern | −0.337 | 0.460 | −0.403 | 0.371 | −0.109 | 0.764 | 0.385 | 0.271 | |
| Weight concern | −0.249 | 0.590 | −0.213 | 0.647 | 0.019 | 0.959 | 0.490 | 0.150 | |
| Shape concern | −0.371 | 0.468 | −0.389 | 0.446 | −0.062 | 0.865 | 0.310 | 0.383 | |
| BITE | severity | 0.977 | 0.023* | 0.810 | 0.190 | 0.632 | 0.068 | 0.811 | 0.008* |
| symptom | −0.494 | 0.506 | −0.695 | 0.305 | 0.342 | 0.368 | 0.662 | 0.052 | |
| TAS-20 | −0.541 | 0.347 | 0.101 | 0.872 | −0.263 | 0.463 | −0.005 | 0.990 | |
| BMI | −0.432 | 0.213 | −0.209 | 0.563 | −0.156 | 0.610 | −0.329 | 0.273 | |
Notes: Correlation coefficients were calculated between the symptom scales and mean z scores of [oxyHb] data during the latter half of the task period of the RPSTloss. AN, anorexia nervosa; BN, bulimia nervosa; HADS, Hospital Anxiety and Depression Scale; EDI, the Eating Disorder Inventory; EDE-Q, the Eating Disorder Examination Questionnaire; BITE, the Bulimic Investigatory Test; TAS-20, the 20-item Toronto Alexithymia Scale; BMI, body mass index. r: Pearson’s correlation coefficient, *p<0.05.